Impact of diabetes on the severity of liver disease
- PMID: 17904449
- DOI: 10.1016/j.amjmed.2007.03.025
Impact of diabetes on the severity of liver disease
Abstract
The prevalence of type 2 diabetes is higher in patients who have liver diseases, such as nonalcoholic fatty liver disease, chronic viral hepatitis, hemochromatosis, alcoholic liver disease, and cirrhosis. The development of diabetes in patients with cirrhosis is well recognized, but evidence is emerging that the development of chronic liver disease and progression to cirrhosis may occur after the diagnosis of diabetes and that diabetes plays a role in the initiation and progression of liver injury. This article provides an overview of the evidence for an increased prevalence of diabetes in a range of liver diseases; the effect of diabetes on the severity of disease; the potential mechanisms whereby coexistent diabetes exacerbates progression of hepatic fibrosis; and the impact of obesity, insulin resistance, and type 2 diabetes on clinical outcomes.
Similar articles
-
Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study.Aliment Pharmacol Ther. 2005 Nov;22 Suppl 2:24-7. doi: 10.1111/j.1365-2036.2005.02590.x. Aliment Pharmacol Ther. 2005. PMID: 16225467 Review.
-
Obesity and the liver: developmental perspectives.Semin Liver Dis. 2004 Nov;24(4):381-7. doi: 10.1055/s-2004-860867. Semin Liver Dis. 2004. PMID: 15605306 Review.
-
[Obesity related complications in children and adolescents].Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2006;12(3):223-8. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2006. PMID: 17020660 Review. Polish.
-
Hepatic complications of obesity.Gastroenterol Clin North Am. 2010 Mar;39(1):57-68. doi: 10.1016/j.gtc.2009.12.001. Gastroenterol Clin North Am. 2010. PMID: 20202579 Review.
-
Impact of liver diseases on the development of type 2 diabetes mellitus.World J Gastroenterol. 2011 Dec 28;17(48):5240-5. doi: 10.3748/wjg.v17.i48.5240. World J Gastroenterol. 2011. PMID: 22219592 Free PMC article. Review.
Cited by
-
Alcohol-related cancer morbidity and mortality are stratified using modified albumin platelet product.Sci Rep. 2024 Jan 11;14(1):1052. doi: 10.1038/s41598-023-50778-x. Sci Rep. 2024. PMID: 38200049 Free PMC article.
-
Reduced mortality and morbidity associated with metformin and SGLT2 inhibitor therapy in patients with type 2 diabetes mellitus and cirrhosis.BMC Gastroenterol. 2023 Dec 19;23(1):450. doi: 10.1186/s12876-023-03085-8. BMC Gastroenterol. 2023. PMID: 38114915 Free PMC article.
-
Dual metformin and glucagon-like peptide-1 receptor agonist therapy reduces mortality and hepatic complications in cirrhotic patients with diabetes mellitus.Ann Gastroenterol. 2023 Sep-Oct;36(5):555-563. doi: 10.20524/aog.2023.0814. Epub 2023 Jul 3. Ann Gastroenterol. 2023. PMID: 37664227 Free PMC article.
-
A Prospective Study to Identify the Prevalence of Impaired Glucose Tolerance in Patients With Liver Cirrhosis Using Oral Glucose Tolerance Test.Cureus. 2023 Apr 28;15(4):e38269. doi: 10.7759/cureus.38269. eCollection 2023 Apr. Cureus. 2023. PMID: 37255908 Free PMC article.
-
Cancer of the Liver and its Relationship with Diabetes mellitus.Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221119743. doi: 10.1177/15330338221119743. Technol Cancer Res Treat. 2022. PMID: 36533882 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
